Literature DB >> 30282485

Protective effects of quercetin from oxidative/nitrosative stress under intermittent hypobaric hypoxia exposure in the rat's heart.

I C Chiş1, D Baltaru2, A Dumitrovici3, A Coseriu1, B C Radu1, R Moldovan1, A Mureşan1.   

Abstract

BACKGROUND: Exposure to high altitude in hypobaric hypoxia (HH) is considered to be a physiological oxidative/nitrosative stress. Quercetin (Que) is an effective antioxidant and free radical scavenger against oxidative/nitrosative stress. AIMS: The aim of this study was to investigate the cardioprotective effects of Que in animals exposed to intermittent HH (IHH) and therefore exposed to oxidative/nitrosative stress.
MATERIALS AND METHODS: Wistar albino male rats were exposed to short-term (2 days) or long-term (4 weeks; 5 days/week) IHH in a hypobaric chamber (5,500 m, 8 h/day, 380 mmHg, 12% O2, and 88% N2). Half of the animals received natural antioxidant Que (body weight: 30 mg/kg) daily before each IHH exposure and the remaining rats received vehicle (carboxymethylcellulose solution). Control rats were kept under normobaric normoxia (Nx) and treated in a corresponding manner. One day after the last exposure to IHH, we measured the cardiac hypoxia-induced oxidative/nitrosative stress biomarkers: the malondialdehyde (MDA) level and protein carbonyl (PC) content, the activity of some antioxidant enzymes [superoxide dismutase (SOD) and catalase (CAT)], the nitrite plus nitrate (NOx) production, and the inducible nitric oxide synthase (iNOS) protein expression.
RESULTS: Heart tissue MDA and PC levels, NOx level, and iNOS expression of IHH-exposed rats had increased, and SOD and CAT activities had decreased compared with those of the Nx-exposed rats (control groups). MDA, CP, NOx, and iNOS levels had decreased in Que-treated IHH-exposed rats compared with IHH-exposed rats (control groups). However, Que administration increased SOD and CAT activities of the heart tissue in the IHH-exposed rats.
CONCLUSION: HH exposure increases oxidative/nitrosative stress in heart tissue and Que is an effective cardioprotective agent, which further supports the oxidative cardiac dysfunction induced by hypoxia.

Entities:  

Keywords:  cardioprotection; intermittent hypobaric hypoxia; natural antioxidants; oxidative/nitrosative stress; quercetin

Mesh:

Substances:

Year:  2018        PMID: 30282485     DOI: 10.1556/2060.105.2018.3.23

Source DB:  PubMed          Journal:  Physiol Int        ISSN: 2498-602X            Impact factor:   2.090


  5 in total

Review 1.  Molecular and Biological Functions of Quercetin as a Natural Solution for Cardiovascular Disease Prevention and Treatment.

Authors:  Liaosadat Mirsafaei; Željko Reiner; Rana Shafabakhsh; Zatollah Asemi
Journal:  Plant Foods Hum Nutr       Date:  2020-09       Impact factor: 3.921

Review 2.  Exploration of Lamiaceae in Cardio Vascular Diseases and Functional Foods: Medicine as Food and Food as Medicine.

Authors:  Ishani Chakrabartty; Yugal Kishore Mohanta; Amilia Nongbet; Tapan Kumar Mohanta; Saurov Mahanta; Nibedita Das; Muthupandian Saravanan; Nanaocha Sharma
Journal:  Front Pharmacol       Date:  2022-06-14       Impact factor: 5.988

3.  Network Pharmacology-Based Approach to Investigate the Mechanisms of Mahai Capsules in the Treatment of Cardiovascular Diseases.

Authors:  Minjuan Shi; Bo Li; Qiuzhen Yuan; Xuefeng Gan; Xiao Ren; Shanshan Jiang; Zhuo Liu
Journal:  Evid Based Complement Alternat Med       Date:  2020-05-12       Impact factor: 2.629

Review 4.  Therapeutic application of quercetin in aging-related diseases: SIRT1 as a potential mechanism.

Authors:  Zhifu Cui; Xingtao Zhao; Felix Kwame Amevor; Xiaxia Du; Yan Wang; Diyan Li; Gang Shu; Yaofu Tian; Xiaoling Zhao
Journal:  Front Immunol       Date:  2022-07-22       Impact factor: 8.786

Review 5.  Quercetin: A Bioactive Compound Imparting Cardiovascular and Neuroprotective Benefits: Scope for Exploring Fresh Produce, Their Wastes, and By-Products.

Authors:  Irshad Ul Haq Bhat; Rajeev Bhat
Journal:  Biology (Basel)       Date:  2021-06-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.